Theresa LaVallee was Resigned as Vice President of Translational Medicine and Regulatory Affairs at Parker-Institute-for-Cancer-Immunotherapy

Date of management change: January 14, 2022 

What Happened?

San Francisco, -based Parker-Institute-for-Cancer-Immunotherapy Resigned Theresa LaVallee as Vice President of Translational Medicine and Regulatory Affairs

 

About the Company

For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy breaks down these barriers. The result is groundbreaking new research and an intellectual property model that builds collaboration between researchers, nonprofits and industry all working together to get treatments to patients faster.

 

About the Person

Theresa LaVallee is Vice President of Translational Medicine and Regulatory Affairs at Parker Institute for Cancer Immunotherapy. Previously, Theresa held various senior legal leadership roles in the industry.

 

Info Source

News

 

imageShort Profile

 

Name: Theresa LaVallee

Title: Vice President of Translational Medicine and Regulatory Affairs

Company: Parker Institute for Cancer Immunotherapy

Industry: Healthcare, Pharmaceuticals, and Biotech Other

imageCurrent Contact Info

 

Email: *********@parkerici.org 

Phone:.***.***.*60* 

To get full contact details, please sign in or

 
Your email is safe with us: see our privacy policy
 

Other IT executives who recently changed jobs as well: Ryon Matthew, Van Flein Tom, Cronin Lisa, Baume Whitney, Olson Luke, Jacob-Warren Misha, Bereznay Chris, Viadero Cheryl, Lemberskiy Julia, Rhodes Book Liz, Meltz Mark

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.